Imatinib vs Trastuzumab
Imatinib vs Trastuzumab: Overview
This comparison examines the pharmacological differences between Imatinib and Trastuzumab.
Mechanism of Action
Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.
Trastuzumab: Anti-HER2 monoclonal antibody inhibiting receptor signaling.
Pharmacokinetics
Half-life: Imatinib — 18 hours; Trastuzumab — 28 days.
Chemical Properties
Molecular Formula: Imatinib — C29H31N7O.
Molecular Weight: Imatinib — 493.6030 g/mol.
Type: Imatinib — Small molecule; Trastuzumab — Antibody.